Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer

Figure 8

Validation of immune gene-correlated nomogram in entire GEO dataset. (a) The higher the bar chart, the larger the percentage. (b) 1-, 3-, and 5-year ROC curves for the immune gene-correlated nomogram. (c–e) Stood for the 1-, 3-, and 5-year nomogram calibration curves, respectively. The closer the dotted line fit to the perfect line, the better the predictive power of the nomogram. (f) The decision curve analysis (DCA) for the nomogram. The net benefit was plotted versus the threshold probability. The red line stood for the nomogram. The blue line stood for the treat all, and the green line stood for the treat none.

(a)

(b)

(c)

(d)

(e)

(f)